Click for best price
Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 154.9 million
|
Forecast Market size by 2029 |
US$ 176.9 million
|
| Growth Rate |
CAGR of 1.9% |
Number of Pages |
79 Pages |
Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening type of stroke caused by bleeding in the space surrounding the brain.
This report aims to provide a comprehensive presentation of the global market for Aneurysmal Subarachnoid Hemorrhage Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aneurysmal Subarachnoid Hemorrhage Drugs. This report contains market size and forecasts of Aneurysmal Subarachnoid Hemorrhage Drugs in global, including the following market information:
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Aneurysmal Subarachnoid Hemorrhage Drugs companies in 2022 (%)
The global Aneurysmal Subarachnoid Hemorrhage Drugs market was valued at US$ 154.9 million in 2022 and is projected to reach US$ 176.9 million by 2029, at a CAGR of 1.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global aneurysmal subarachnoid hemorrhage drugs market is segmented based on drug class and region. Based on drug class, the market is segmented into opioid analgesic, calcium channel blocker, anticonvulsant, stool softener, osmotic agent/diuretic, and other drugs.
We surveyed the Aneurysmal Subarachnoid Hemorrhage Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Segment Percentages, by Type, 2022 (%)
Opioid Analgesic
Calcium Channel Blocker
Anticonvulsant
Stool Softener
Osmotic Agent
Other Drugs
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Aneurysmal Subarachnoid Hemorrhage Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Aneurysmal Subarachnoid Hemorrhage Drugs revenues share in global market, 2022 (%)
Key companies Aneurysmal Subarachnoid Hemorrhage Drugs sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Aneurysmal Subarachnoid Hemorrhage Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Arbor Pharmaceuticals
PDS Biotechnology Corporation
Johnson and Johnson
Mylan N.V
Orexo AB
Pfizer
Purdue Pharma
Pharmaxis
Sun Pharmaceutical Industries
Teva Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Aneurysmal Subarachnoid Hemorrhage Drugs, market overview.
Chapter 2: Global Aneurysmal Subarachnoid Hemorrhage Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Aneurysmal Subarachnoid Hemorrhage Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Aneurysmal Subarachnoid Hemorrhage Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Aneurysmal Subarachnoid Hemorrhage Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Aneurysmal Subarachnoid Hemorrhage Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 154.9 million
|
| Forecast Market size by 2029 |
US$ 176.9 million
|
| Growth Rate |
CAGR of 1.9% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
79 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Aneurysmal Subarachnoid Hemorrhage Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Overall Market Size
2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size: 2022 VS 2029
2.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Aneurysmal Subarachnoid Hemorrhage Drugs Players in Global Market
3.2 Top Global Aneurysmal Subarachnoid Hemorrhage Drugs Companies Ranked by Revenue
3.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Companies
3.4 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Companies
3.5 Global Aneurysmal Subarachnoid Hemorrhage Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Aneurysmal Subarachnoid Hemorrhage Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Aneurysmal Subarachnoid Hemorrhage Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Aneurysmal Subarachnoid Hemorrhage Drugs Players in Global Market
3.8.1 List of Global Tier 1 Aneurysmal Subarachnoid Hemorrhage Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Aneurysmal Subarachnoid Hemorrhage Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Markets, 2022 & 2029
4.1.2 Opioid Analgesic
4.1.3 Calcium Channel Blocker
4.1.4 Anticonvulsant
4.1.5 Stool Softener
4.1.6 Osmotic Agent
4.1.7 Other Drugs
4.2 By Type - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue & Forecasts
4.2.1 By Type - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2018-2023
4.2.2 By Type - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2024-2029
4.2.3 By Type - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales & Forecasts
4.3.1 By Type - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2018-2023
4.3.2 By Type - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2024-2029
4.3.3 By Type - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Aneurysmal Subarachnoid Hemorrhage Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue & Forecasts
5.2.1 By Application - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2018-2023
5.2.2 By Application - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2024-2029
5.2.3 By Application - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales & Forecasts
5.3.1 By Application - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2018-2023
5.3.2 By Application - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2024-2029
5.3.3 By Application - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Aneurysmal Subarachnoid Hemorrhage Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2022 & 2029
6.2 By Region - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue & Forecasts
6.2.1 By Region - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2018-2023
6.2.2 By Region - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2024-2029
6.2.3 By Region - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales & Forecasts
6.3.1 By Region - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2018-2023
6.3.2 By Region - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2024-2029
6.3.3 By Region - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2018-2029
6.4.2 By Country - North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2018-2029
6.4.3 US Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.4.4 Canada Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.4.5 Mexico Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2018-2029
6.5.3 Germany Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.5.4 France Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.5.5 U.K. Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.5.6 Italy Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.5.7 Russia Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.5.9 Benelux Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2018-2029
6.6.3 China Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.6.4 Japan Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.6.5 South Korea Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.6.7 India Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2018-2029
6.7.2 By Country - South America Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2018-2029
6.7.3 Brazil Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.7.4 Argentina Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2018-2029
6.8.3 Turkey Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.8.4 Israel Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.8.6 UAE Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Arbor Pharmaceuticals
7.1.1 Arbor Pharmaceuticals Company Summary
7.1.2 Arbor Pharmaceuticals Business Overview
7.1.3 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Major Product Offerings
7.1.4 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Arbor Pharmaceuticals Key News & Latest Developments
7.2 PDS Biotechnology Corporation
7.2.1 PDS Biotechnology Corporation Company Summary
7.2.2 PDS Biotechnology Corporation Business Overview
7.2.3 PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Major Product Offerings
7.2.4 PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in Global (2018-2023)
7.2.5 PDS Biotechnology Corporation Key News & Latest Developments
7.3 Johnson and Johnson
7.3.1 Johnson and Johnson Company Summary
7.3.2 Johnson and Johnson Business Overview
7.3.3 Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Major Product Offerings
7.3.4 Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Johnson and Johnson Key News & Latest Developments
7.4 Mylan N.V
7.4.1 Mylan N.V Company Summary
7.4.2 Mylan N.V Business Overview
7.4.3 Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Major Product Offerings
7.4.4 Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Mylan N.V Key News & Latest Developments
7.5 Orexo AB
7.5.1 Orexo AB Company Summary
7.5.2 Orexo AB Business Overview
7.5.3 Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Major Product Offerings
7.5.4 Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Orexo AB Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Major Product Offerings
7.6.4 Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Purdue Pharma
7.7.1 Purdue Pharma Company Summary
7.7.2 Purdue Pharma Business Overview
7.7.3 Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Major Product Offerings
7.7.4 Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Purdue Pharma Key News & Latest Developments
7.8 Pharmaxis
7.8.1 Pharmaxis Company Summary
7.8.2 Pharmaxis Business Overview
7.8.3 Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Major Product Offerings
7.8.4 Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Pharmaxis Key News & Latest Developments
7.9 Sun Pharmaceutical Industries
7.9.1 Sun Pharmaceutical Industries Company Summary
7.9.2 Sun Pharmaceutical Industries Business Overview
7.9.3 Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Major Product Offerings
7.9.4 Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.10 Teva Pharmaceutical
7.10.1 Teva Pharmaceutical Company Summary
7.10.2 Teva Pharmaceutical Business Overview
7.10.3 Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Major Product Offerings
7.10.4 Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Teva Pharmaceutical Key News & Latest Developments
8 Global Aneurysmal Subarachnoid Hemorrhage Drugs Production Capacity, Analysis
8.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Production Capacity, 2018-2029
8.2 Aneurysmal Subarachnoid Hemorrhage Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Aneurysmal Subarachnoid Hemorrhage Drugs Supply Chain Analysis
10.1 Aneurysmal Subarachnoid Hemorrhage Drugs Industry Value Chain
10.2 Aneurysmal Subarachnoid Hemorrhage Drugs Upstream Market
10.3 Aneurysmal Subarachnoid Hemorrhage Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Aneurysmal Subarachnoid Hemorrhage Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Aneurysmal Subarachnoid Hemorrhage Drugs in Global Market
Table 2. Top Aneurysmal Subarachnoid Hemorrhage Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Companies, (K MT), 2018-2023
Table 6. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Aneurysmal Subarachnoid Hemorrhage Drugs Price (2018-2023) & (USD/MT)
Table 8. Global Manufacturers Aneurysmal Subarachnoid Hemorrhage Drugs Product Type
Table 9. List of Global Tier 1 Aneurysmal Subarachnoid Hemorrhage Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Aneurysmal Subarachnoid Hemorrhage Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), 2018-2023
Table 15. By Type - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), 2024-2029
Table 16. By Application ? Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), 2018-2023
Table 20. By Application - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), 2024-2029
Table 21. By Region ? Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), 2018-2023
Table 25. By Region - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), 2024-2029
Table 26. By Country - North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales, (K MT), 2018-2023
Table 29. By Country - North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales, (K MT), 2024-2029
Table 30. By Country - Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales, (K MT), 2018-2023
Table 33. By Country - Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales, (K MT), 2024-2029
Table 34. By Region - Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales, (K MT), 2018-2023
Table 37. By Region - Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales, (K MT), 2024-2029
Table 38. By Country - South America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Aneurysmal Subarachnoid Hemorrhage Drugs Sales, (K MT), 2018-2023
Table 41. By Country - South America Aneurysmal Subarachnoid Hemorrhage Drugs Sales, (K MT), 2024-2029
Table 42. By Country - Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales, (K MT), 2018-2023
Table 45. By Country - Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales, (K MT), 2024-2029
Table 46. Arbor Pharmaceuticals Company Summary
Table 47. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Product Offerings
Table 48. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 49. Arbor Pharmaceuticals Key News & Latest Developments
Table 50. PDS Biotechnology Corporation Company Summary
Table 51. PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Product Offerings
Table 52. PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 53. PDS Biotechnology Corporation Key News & Latest Developments
Table 54. Johnson and Johnson Company Summary
Table 55. Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Product Offerings
Table 56. Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 57. Johnson and Johnson Key News & Latest Developments
Table 58. Mylan N.V Company Summary
Table 59. Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Product Offerings
Table 60. Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 61. Mylan N.V Key News & Latest Developments
Table 62. Orexo AB Company Summary
Table 63. Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Product Offerings
Table 64. Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 65. Orexo AB Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Product Offerings
Table 68. Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. Purdue Pharma Company Summary
Table 71. Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Product Offerings
Table 72. Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 73. Purdue Pharma Key News & Latest Developments
Table 74. Pharmaxis Company Summary
Table 75. Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Product Offerings
Table 76. Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 77. Pharmaxis Key News & Latest Developments
Table 78. Sun Pharmaceutical Industries Company Summary
Table 79. Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Product Offerings
Table 80. Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 81. Sun Pharmaceutical Industries Key News & Latest Developments
Table 82. Teva Pharmaceutical Company Summary
Table 83. Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Product Offerings
Table 84. Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 85. Teva Pharmaceutical Key News & Latest Developments
Table 86. Aneurysmal Subarachnoid Hemorrhage Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2021-2023 (K MT)
Table 87. Global Aneurysmal Subarachnoid Hemorrhage Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Aneurysmal Subarachnoid Hemorrhage Drugs Production by Region, 2018-2023 (K MT)
Table 89. Global Aneurysmal Subarachnoid Hemorrhage Drugs Production by Region, 2024-2029 (K MT)
Table 90. Aneurysmal Subarachnoid Hemorrhage Drugs Market Opportunities & Trends in Global Market
Table 91. Aneurysmal Subarachnoid Hemorrhage Drugs Market Drivers in Global Market
Table 92. Aneurysmal Subarachnoid Hemorrhage Drugs Market Restraints in Global Market
Table 93. Aneurysmal Subarachnoid Hemorrhage Drugs Raw Materials
Table 94. Aneurysmal Subarachnoid Hemorrhage Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Aneurysmal Subarachnoid Hemorrhage Drugs Downstream
Table 96. Aneurysmal Subarachnoid Hemorrhage Drugs Downstream Clients in Global Market
Table 97. Aneurysmal Subarachnoid Hemorrhage Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Aneurysmal Subarachnoid Hemorrhage Drugs Segment by Type in 2022
Figure 2. Aneurysmal Subarachnoid Hemorrhage Drugs Segment by Application in 2022
Figure 3. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Aneurysmal Subarachnoid Hemorrhage Drugs Sales in Global Market: 2018-2029 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Aneurysmal Subarachnoid Hemorrhage Drugs Revenue in 2022
Figure 9. By Type - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Aneurysmal Subarachnoid Hemorrhage Drugs Price (USD/MT), 2018-2029
Figure 13. By Application - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Aneurysmal Subarachnoid Hemorrhage Drugs Price (USD/MT), 2018-2029
Figure 17. By Region - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share, 2018-2029
Figure 23. US Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share, 2018-2029
Figure 28. Germany Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share, 2018-2029
Figure 37. China Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Aneurysmal Subarachnoid Hemorrhage Drugs Production Capacity (K MT), 2018-2029
Figure 53. The Percentage of Production Aneurysmal Subarachnoid Hemorrhage Drugs by Region, 2022 VS 2029
Figure 54. Aneurysmal Subarachnoid Hemorrhage Drugs Industry Value Chain
Figure 55. Marketing Channels
